MX2015006757A - Método para la evaluación de la presencia de o riesgo de tumores de colon. - Google Patents
Método para la evaluación de la presencia de o riesgo de tumores de colon.Info
- Publication number
- MX2015006757A MX2015006757A MX2015006757A MX2015006757A MX2015006757A MX 2015006757 A MX2015006757 A MX 2015006757A MX 2015006757 A MX2015006757 A MX 2015006757A MX 2015006757 A MX2015006757 A MX 2015006757A MX 2015006757 A MX2015006757 A MX 2015006757A
- Authority
- MX
- Mexico
- Prior art keywords
- colum
- tumors
- evaluating
- risk
- patient
- Prior art date
Links
Classifications
-
- G01N33/57535—
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57419—Specifically defined cancers of colon
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
- G16B40/20—Supervised data analysis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/70—Mechanisms involved in disease identification
- G01N2800/7023—(Hyper)proliferation
- G01N2800/7028—Cancer
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medical Informatics (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Theoretical Computer Science (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Evolutionary Biology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Data Mining & Analysis (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Artificial Intelligence (AREA)
- Bioethics (AREA)
- Biomedical Technology (AREA)
- Software Systems (AREA)
- Databases & Information Systems (AREA)
- Epidemiology (AREA)
- Evolutionary Computation (AREA)
- Public Health (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261732024P | 2012-11-30 | 2012-11-30 | |
| US201361772979P | 2013-03-05 | 2013-03-05 | |
| PCT/US2013/072691 WO2014085826A2 (en) | 2012-11-30 | 2013-12-02 | Method for evaluation of presence of or risk of colon tumors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2015006757A true MX2015006757A (es) | 2015-11-30 |
Family
ID=50828610
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2015006757A MX2015006757A (es) | 2012-11-30 | 2013-12-02 | Método para la evaluación de la presencia de o riesgo de tumores de colon. |
Country Status (11)
| Country | Link |
|---|---|
| US (6) | US20140234854A1 (enExample) |
| EP (1) | EP2926138A4 (enExample) |
| JP (1) | JP2016507723A (enExample) |
| KR (1) | KR20150090240A (enExample) |
| CN (2) | CN104969071B (enExample) |
| AU (1) | AU2013351947A1 (enExample) |
| BR (1) | BR112015012616A2 (enExample) |
| CA (1) | CA2893158A1 (enExample) |
| MX (1) | MX2015006757A (enExample) |
| SG (1) | SG11201504241QA (enExample) |
| WO (1) | WO2014085826A2 (enExample) |
Families Citing this family (63)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9141756B1 (en) | 2010-07-20 | 2015-09-22 | University Of Southern California | Multi-scale complex systems transdisciplinary analysis of response to therapy |
| IN2014MN01780A (enExample) | 2012-02-09 | 2015-07-03 | Memed Diagnostics Ltd | |
| CA2943827A1 (en) * | 2014-03-28 | 2015-10-01 | Applied Proteomics, Inc. | Protein biomarker profiles for detecting colorectal tumors |
| CN106489075B (zh) * | 2014-07-11 | 2019-10-15 | 爱科谱迅病理研究公司 | 针对GTP酶KRas蛋白质(KRas)的SRM/MRM测定 |
| US10303846B2 (en) | 2014-08-14 | 2019-05-28 | Memed Diagnostics Ltd. | Computational analysis of biological data using manifold and a hyperplane |
| KR20170126846A (ko) * | 2014-09-05 | 2017-11-20 | 난토믹스, 엘엘씨 | 출처의 결정을 위한 시스템들 및 방법들 |
| CN107209184B (zh) | 2014-12-11 | 2020-04-24 | 米密德诊断学有限公司 | 用于诊断多种感染的标记组合及其使用方法 |
| EP3230743A1 (en) * | 2014-12-11 | 2017-10-18 | Wisconsin Alumni Research Foundation | Methods for detection and treatment of colorectal cancer |
| CN105807062A (zh) * | 2014-12-28 | 2016-07-27 | 复旦大学 | 人结肠癌蛋白Spondin-2在制备结肠癌诊断制剂中的应用 |
| CN105385752A (zh) * | 2015-03-23 | 2016-03-09 | 复旦大学 | 一种人结肠癌蛋白质标志物Spondin-2的检测方法及其检测试剂盒 |
| JP2018517892A (ja) * | 2015-04-10 | 2018-07-05 | アプライド プロテオミクス，インク． | 結腸直腸癌と進行腺腫を検知するためのタンパク質バイオマーカーパネル |
| EP3974539A1 (en) * | 2015-07-01 | 2022-03-30 | Duke University | Methods to diagnose and treat acute respiratory infections |
| US11047860B2 (en) * | 2015-11-05 | 2021-06-29 | Vanderbilt University | Protein quantitation in multicellular tissue specimens |
| EP3423590A4 (en) | 2016-03-03 | 2020-02-26 | Memed Diagnostics Ltd. | DETERMINANTS OF RNA TO DIFFERENTIATE BACTERIAL VIRAL INFECTIONS |
| CN109416926A (zh) * | 2016-04-11 | 2019-03-01 | 迪森德克斯公司 | 质谱数据分析工作流程 |
| JP6754116B2 (ja) * | 2016-04-26 | 2020-09-09 | 学校法人近畿大学 | 大腸癌マーカー |
| CN107345236A (zh) * | 2016-05-04 | 2017-11-14 | 北京美泽福临科技发展有限公司 | 一种amy2b信使rna的特异性扩增引物和肝癌辅助诊断试剂盒 |
| AU2017278305B2 (en) * | 2016-06-10 | 2023-11-23 | Wisconsin Alumni Research Foundation | Methods for detection, staging, and surveillance of colorectal adenomas and carcinomas |
| WO2018011796A1 (en) | 2016-07-10 | 2018-01-18 | Memed Diagnostics Ltd. | Early diagnosis of infections |
| EP3482200B1 (en) | 2016-07-10 | 2022-05-04 | Memed Diagnostics Ltd. | Protein signatures for distinguishing between bacterial and viral infections |
| CN106202984B (zh) * | 2016-08-26 | 2018-09-04 | 赵毅 | 一种基于多层复杂网络对肿瘤miRNA标志物的筛选方法 |
| CN110073220A (zh) * | 2016-09-29 | 2019-07-30 | 米密德诊断学有限公司 | 风险评估和疾病分类的方法 |
| WO2018060998A1 (en) | 2016-09-29 | 2018-04-05 | Memed Diagnostics Ltd. | Methods of prognosis and treatment |
| US20180100858A1 (en) * | 2016-10-07 | 2018-04-12 | Applied Proteomics, Inc. | Protein biomarker panels for detecting colorectal cancer and advanced adenoma |
| EP3572805A4 (en) | 2017-01-19 | 2020-09-16 | Shimadzu Corporation | ANALYSIS DATA ANALYSIS PROCESS AND ANALYSIS DATA ANALYSIS DEVICE |
| US11204355B2 (en) | 2017-02-20 | 2021-12-21 | Vanderbilt University | Immune checkpoint molecular fitness profiling by mass spectrometry |
| CN106919801B (zh) * | 2017-03-08 | 2023-07-18 | 杭州大伽信息科技有限公司 | 一种免疫组织化学染色辅助分析系统及使用方法 |
| CN106908608B (zh) * | 2017-04-17 | 2018-10-02 | 首都医科大学附属北京胸科医院 | 辅助诊断重症继发性肺结核的蛋白标志物 |
| US20180330059A1 (en) * | 2017-05-09 | 2018-11-15 | James Stewart Bates | Patient treatment systems and methods |
| US10455457B2 (en) | 2017-05-24 | 2019-10-22 | Qualcomm Incorporated | NR-SS unified operation mode in coordinated and uncoordinated bands |
| US11164679B2 (en) | 2017-06-20 | 2021-11-02 | Advinow, Inc. | Systems and methods for intelligent patient interface exam station |
| CA3068688A1 (en) * | 2017-06-30 | 2019-01-03 | National Institutes Of Biomedical Innovation, Health And Nutrition | Biomarker for detecting colorectal cancer |
| AU2018301704A1 (en) * | 2017-07-14 | 2020-03-05 | Cofactor Genomics, Inc. | Immuno-oncology applications using next generation sequencing |
| CN109406785A (zh) * | 2017-08-18 | 2019-03-01 | 山东泽济生物科技有限公司 | 肿瘤血液标志物及其应用 |
| WO2019113239A1 (en) * | 2017-12-05 | 2019-06-13 | Discerndx, Inc. | Robust panels of colorectal cancer biomarkers |
| EP3732489B1 (en) * | 2017-12-29 | 2025-10-22 | Abbott Laboratories | Novel biomarkers and methods for diagnosing and evaluating traumatic brain injury |
| US11414707B2 (en) | 2018-01-22 | 2022-08-16 | Liquid Biopsy Research LLC | Methods for colon cancer detection and treatment |
| US11348688B2 (en) | 2018-03-06 | 2022-05-31 | Advinow, Inc. | Systems and methods for audio medical instrument patient measurements |
| KR102898867B1 (ko) | 2018-04-13 | 2025-12-12 | 프리놈 홀딩스, 인크. | 생물학적 샘플의 다중 분석물 검정을 위한 기계 학습 구현 |
| EP3818376A1 (en) * | 2018-07-05 | 2021-05-12 | EDP Biotech Corporation | Kits and methods for detecting markers |
| EA202190355A1 (ru) * | 2018-08-08 | 2021-05-25 | Ридженерон Фармасьютикалз, Инк. | Применение жх-мс/мс для количественного определения белковых биомаркеров |
| EP3623813A1 (en) * | 2018-09-17 | 2020-03-18 | Institut d'Investigació Sanitària Pere Virgili | Methods for the prognosis of hiv-infected subjects |
| EP3935394A1 (en) * | 2019-03-06 | 2022-01-12 | Diadem S.r.l. | P53 peptides as markers in the diagnosis and prognosis of alzheimer's disease |
| WO2021097302A1 (en) * | 2019-11-13 | 2021-05-20 | University Of South Florida | Systems and methods of deep learning for colorectal polyp screening |
| CN110951707B (zh) * | 2019-12-31 | 2022-11-11 | 南京医科大学 | 丙酮酸激酶m2突变体及其在心血管疾病中的应用 |
| CN115616230A (zh) * | 2020-03-18 | 2023-01-17 | 龙海市第一医院 | 用于肝癌早期诊断的检测岩藻糖基化载脂蛋白h的elisa试剂盒 |
| WO2022006628A1 (en) * | 2020-07-08 | 2022-01-13 | Southern Adelaide Local Health Network Inc. | Computer-implemented method and system for identifying measurable features for use in a predictive model |
| CN112194719A (zh) * | 2020-09-01 | 2021-01-08 | 中日友好医院(中日友好临床医学研究所) | Crt抗原和mage-a1抗原的制备及其应用 |
| CN112034182A (zh) * | 2020-09-01 | 2020-12-04 | 复旦大学附属中山医院 | 一种结肠癌转移预测方法和系统 |
| CN112266961B (zh) * | 2020-10-29 | 2023-05-12 | 中山大学附属第六医院 | Tsg-6基因在预测结直肠癌转移及预后方面的应用 |
| CN112710856B (zh) * | 2020-12-16 | 2022-12-02 | 江西省肿瘤医院(江西省癌症中心) | 检测血清igf1蛋白的制剂在制备结直肠癌疗效监测试剂中的应用 |
| CN114878833A (zh) * | 2021-07-01 | 2022-08-09 | 浙江大学 | 一种检测抗过氧化物还原酶-1-IgG抗体的试剂盒 |
| CN113956327B (zh) * | 2021-10-11 | 2024-01-30 | 中山大学肿瘤防治中心 | 靶向人apc蛋白的多肽及其在制备药物中的应用 |
| WO2023183481A1 (en) * | 2022-03-23 | 2023-09-28 | Serum Detect, Inc. | Biomarker signatures indicative of early stages of cancer |
| CN114445406B (zh) * | 2022-04-07 | 2022-08-09 | 武汉大学 | 肠镜图像分析方法、装置和医学图像处理设备 |
| TWI796228B (zh) | 2022-05-25 | 2023-03-11 | 臺中榮民總醫院 | 急性腎損傷預測系統及其方法 |
| CN114668836B (zh) * | 2022-05-27 | 2022-08-19 | 暨南大学 | Pdia6在制备治疗脊髓损伤和修复的药物中的应用 |
| CN114958794B (zh) * | 2022-06-14 | 2023-06-02 | 南京工业大学 | 一种苯乙醇胺-N-甲基转移酶hPNMT54及其克隆表达与应用 |
| CN116593431B (zh) * | 2023-04-09 | 2025-11-07 | 湖南科技大学三亚研究院 | 一种基于亲和传感器法的米酵菌酸毒素便携式检测装置及检测方法 |
| US20240379228A1 (en) * | 2023-05-08 | 2024-11-14 | Venn Biosciences Corporation | Diagnosis of colorectal cancer using targeted quantification of peptides |
| WO2025058445A1 (ko) * | 2023-09-15 | 2025-03-20 | 연세대학교 산학협력단 | 대장암에 대한 정보 제공 방법 |
| CN118067993B (zh) * | 2024-04-17 | 2024-07-05 | 弗雷米德生物医药技术（天津）有限公司 | 一种用于肠息肉检测的联检试剂盒及其制备方法、检测方法和应用 |
| CN118496322A (zh) * | 2024-05-09 | 2024-08-16 | 昆明医科大学 | 一种靶向降解β-catenin的多肽型抑制剂及其应用 |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4444879A (en) * | 1981-01-29 | 1984-04-24 | Science Research Center, Inc. | Immunoassay with article having support film and immunological counterpart of analyte |
| US4517289A (en) * | 1982-08-18 | 1985-05-14 | Brigham And Women's Hospital | Monoclonal antibodies for human tissue cross-matching |
| EP0854934A4 (en) * | 1995-08-18 | 2000-09-06 | Donald W Landry | DETECTION OF ORGANIC COMPOUNDS BY REGULATION OF ANTIBODY CATALYZED REACTIONS |
| US5800347A (en) * | 1995-11-03 | 1998-09-01 | The General Hospital Corporation | ROC method for early detection of disease |
| NO954667D0 (no) * | 1995-11-17 | 1995-11-17 | Dagfinn Oegreid | Fremgangsmåte til deteksjon av Ki-ras mutasjoner |
| WO2000070096A2 (en) * | 1999-01-10 | 2000-11-23 | Exact Laboratories, Inc. | Methods of detecting colorectal disease by conduction an assay to detect a mutation in a bat-26 locus |
| US20010041365A1 (en) * | 2000-01-10 | 2001-11-15 | Michael Laposata | Methods for monitoring alcohol consumption |
| US20040018973A1 (en) * | 2002-01-25 | 2004-01-29 | University Of Pittsburgh | Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof |
| US20050153382A1 (en) * | 2002-06-06 | 2005-07-14 | Chengdu Kuachang Science And Technology Co., Ltd. | Biochip kit comprising biochip based on antigen-antibody reactions, and its usage |
| EP2336779B1 (en) * | 2004-02-19 | 2013-07-31 | Yale University | Kit for the identification of ovarian cancer protein biomarkers using proteomic techniques |
| CA2577601A1 (en) * | 2004-08-13 | 2006-02-16 | Indivumed Gmbh | Use of transthyretin as a biomarker for colorectal adenoma and/or carcinoma; method for detection and test system |
| US20060105419A1 (en) * | 2004-08-16 | 2006-05-18 | Biosite, Inc. | Use of a glutathione peroxidase 1 as a marker in cardiovascular conditions |
| WO2006094149A2 (en) * | 2005-03-01 | 2006-09-08 | Exact Sciences Corporation | Methods and compositions for detecting adenoma |
| CN101283280A (zh) * | 2005-08-18 | 2008-10-08 | Zadec私人有限公司 | 用于诊断结直肠癌的蛋白质标记和所述标记作为所述癌症类型治疗的药物靶点的用途 |
| WO2007141595A2 (en) * | 2005-11-10 | 2007-12-13 | Aurelium Biopharma Inc. | Method of diagnosing breast cancer using protein markers |
| ES2565512T3 (es) * | 2007-07-19 | 2016-04-05 | bioMérieux | Procedimiento de ensayo de la proteína de unión a ácidos grasos del hígado, de ACE y de CA19-9 para el diagnóstico in vitro del cáncer colorrectal |
| WO2009040782A2 (en) * | 2007-09-28 | 2009-04-02 | Royal College Of Surgeons In Ireland | A method of assessing colorectal cancer status in an individual |
| ES2527649T3 (es) * | 2007-12-10 | 2015-01-28 | F. Hoffmann-La Roche Ag | Panel de marcadores para el cáncer colorrectal |
| MX2010004671A (es) * | 2007-12-10 | 2010-05-27 | Hoffmann La Roche | Seprasa como marcador para cancer. |
| US20110097271A1 (en) * | 2008-02-11 | 2011-04-28 | Hadasit Medical Research Services & Development Li | Colon Cancer Associated Transcript 1 (CCAT1) As A Cancer Marker |
| WO2009107170A1 (ja) * | 2008-02-29 | 2009-09-03 | 学校法人日本大学 | 抗ｃｒｐ抗体及びその利用 |
| WO2009115920A1 (en) * | 2008-03-18 | 2009-09-24 | Epigenomics Ag | A method for optimizing and validating an assay for determining the presence or absence of a medical condition |
| JP2011521215A (ja) * | 2008-05-14 | 2011-07-21 | エーテーハー チューリヒ | 前立腺癌の診断及び治療のためのバイオマーカー及び薬剤標的発見法、並びにそれを用いて決定されるバイオマーカーアッセイ |
| ES2506116T3 (es) * | 2008-05-23 | 2014-10-13 | Biocartis Nv | Nuevo biomarcador para diagnóstico, predicción y/o pronóstico de septicemia y usos del mismo |
| CN102858991A (zh) * | 2009-10-15 | 2013-01-02 | 克雷桑多生物科技公司 | 生物标志物及炎性疾病活动性的测量和监测方法 |
| US10119959B2 (en) * | 2010-06-25 | 2018-11-06 | The Board Of Trustees Of The Leland Stanford Junior University | Method of assaying an individual for immune impairment |
| EP2668503B1 (en) * | 2011-01-28 | 2015-06-24 | F.Hoffmann-La Roche Ag | Combinatorial biomarkers for clinical applications in lung cancer patient management |
| WO2012115885A1 (en) * | 2011-02-22 | 2012-08-30 | Caris Life Sciences Luxembourg Holdings, S.A.R.L. | Circulating biomarkers |
| EP2744919A4 (en) * | 2011-08-19 | 2015-04-08 | Myriad Genetics Inc | GENE SIGNATURES FOR PROGNOSIS OF LUNG CANCER AND SELECTION OF THERAPY |
-
2013
- 2013-12-02 WO PCT/US2013/072691 patent/WO2014085826A2/en not_active Ceased
- 2013-12-02 EP EP13858410.7A patent/EP2926138A4/en not_active Ceased
- 2013-12-02 CN CN201380071930.XA patent/CN104969071B/zh not_active Expired - Fee Related
- 2013-12-02 US US14/094,594 patent/US20140234854A1/en not_active Abandoned
- 2013-12-02 JP JP2015545504A patent/JP2016507723A/ja active Pending
- 2013-12-02 BR BR112015012616A patent/BR112015012616A2/pt not_active IP Right Cessation
- 2013-12-02 AU AU2013351947A patent/AU2013351947A1/en not_active Abandoned
- 2013-12-02 CN CN201910577840.7A patent/CN110596385A/zh active Pending
- 2013-12-02 SG SG11201504241QA patent/SG11201504241QA/en unknown
- 2013-12-02 MX MX2015006757A patent/MX2015006757A/es unknown
- 2013-12-02 KR KR1020157017551A patent/KR20150090240A/ko not_active Withdrawn
- 2013-12-02 CA CA2893158A patent/CA2893158A1/en not_active Abandoned
-
2014
- 2014-10-28 US US14/526,282 patent/US20150111221A1/en not_active Abandoned
- 2014-10-28 US US14/526,221 patent/US20150111220A1/en not_active Abandoned
- 2014-10-28 US US14/526,181 patent/US20150111223A1/en not_active Abandoned
- 2014-10-28 US US14/526,265 patent/US20150111230A1/en not_active Abandoned
-
2017
- 2017-06-14 US US15/622,340 patent/US20170285033A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| KR20150090240A (ko) | 2015-08-05 |
| EP2926138A4 (en) | 2016-09-14 |
| WO2014085826A2 (en) | 2014-06-05 |
| CN110596385A (zh) | 2019-12-20 |
| BR112015012616A2 (pt) | 2017-09-12 |
| SG11201504241QA (en) | 2015-06-29 |
| CN104969071A (zh) | 2015-10-07 |
| CN104969071B (zh) | 2019-09-03 |
| US20170285033A1 (en) | 2017-10-05 |
| CA2893158A1 (en) | 2014-06-05 |
| US20150111230A1 (en) | 2015-04-23 |
| US20140234854A1 (en) | 2014-08-21 |
| US20150111220A1 (en) | 2015-04-23 |
| JP2016507723A (ja) | 2016-03-10 |
| US20150111221A1 (en) | 2015-04-23 |
| AU2013351947A1 (en) | 2015-06-18 |
| WO2014085826A3 (en) | 2014-10-23 |
| EP2926138A2 (en) | 2015-10-07 |
| US20150111223A1 (en) | 2015-04-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2015006757A (es) | Método para la evaluación de la presencia de o riesgo de tumores de colon. | |
| Daughton | Using biomarkers in sewage to monitor community-wide human health: Isoprostanes as conceptual prototype | |
| HK1255533A1 (zh) | 用於检测大肠癌及进阶性腺瘤的蛋白质生物标志物面板 | |
| MX2020001156A (es) | Metodo para el pronostico y tratamiento de metastasis de cancer. | |
| AR098155A1 (es) | Métodos para diagnosticar y tratar trastornos eosinofílicos | |
| MX361058B (es) | Método para detectar células tumorales circulantes 5t4-positivas y métodos de diagnóstico de cáncer 5t4-positivo en un sujeto mamífero. | |
| WO2014020502A3 (en) | Markers associated with sensitivity to inhibitors of human double minute 2 (mdm2) | |
| EA201590773A1 (ru) | Способ диагностики для прогнозирования ответа на ингибитор фактора некроза опухоли альфа (tnf альфа) | |
| GB201021399D0 (en) | Oligonucleotide probe set and methods of microbiota profiling | |
| MX2016012697A (es) | Perfiles de marcadores biologicos de proteina para detectar tumores colorrectales. | |
| HK1248316B (zh) | 评估个体结肠直肠健康的方法 | |
| MX368099B (es) | Biomarcadores para predecir y evaluar el grado de respuesta de sujetos con cancer de endometrio a compuestos de tipo lenvatinib. | |
| AR095363A1 (es) | Biomarcadores y métodos para el tratamiento de condiciones relacionadas con pd-1 y pd-l1 | |
| WO2013028680A3 (en) | Method and apparatus for detecting a biomarker in the presence of electrical stimulation | |
| BR112013001752A2 (pt) | método de detectar doenças ou condições usando células fagocídicas | |
| BRPI0509979A (pt) | método para detectar ncrna | |
| CR20130070A (es) | Ensayos biomarcadores para detectar o medir inhibición de actividad quinasa tor | |
| EA201390150A1 (ru) | Способы выявления сигнатур заболевания или патологических состояний в текучих средах организма | |
| BR112013023050A2 (pt) | antagonista de ccr5, método para determinar se um indivíduo humano tendo câncer de próstata está sofrendo de ou sob o risco de desenvolver metástase, para identificar um composto candidato, para produzir in vitro células epiteliais primárias, para diagnosticar câncer de próstata, para selecionar um tratamento para um indivíduo tendo um câncer/tumor de próstata, linhagem de célula, e, modelo animal | |
| BR112014009643A2 (pt) | métodos para diagnosticar ou detectar neoplasia colorretal em um sujeito humano, biomarcador para progressão de doença e kits para um diagnóstico de neoplasia colorretal | |
| BR112013010015A2 (pt) | aparelho e método para detecção não invasiva de doenças que afetam as propriedades estruturais em tecidos biológicos | |
| EP2598873A4 (en) | BIOMARKERS FOR PROSTATE CANCER AND METHOD FOR THEIR USE | |
| JP2014144959A5 (enExample) | ||
| HK1197085A1 (en) | Genetic variants for predicting risk of breast cancer | |
| MX360236B (es) | Uso de marcadores en el diagnostico y tratamiento de cancer de prostata. |